Pfizer Inc. (PFE)
25.78
+0.44
(+1.76%)
USD |
NYSE |
Dec 10, 16:00
25.77
0.00 (0.00%)
After-Hours: 18:35
Pfizer Cash from Investing (Quarterly): -2.43B for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
| Viking Therapeutics, Inc. | 160.02M |
| Arvinas, Inc. | 63.50M |
| Moderna, Inc. | 700.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.603B |
| Cash from Financing (Quarterly) | -2.476B |
| Free Cash Flow | 10.38B |
| Free Cash Flow Per Share (Quarterly) | 0.7002 |
| Free Cash Flow to Equity (Quarterly) | 4.086B |
| Free Cash Flow to Firm (Quarterly) | 4.695B |
| Free Cash Flow Yield | 7.05% |